AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇳🇬

Golimumab in Nigeria

2 products registered with NAFDAC 2 active

Brand / ProductReg. No.HolderStatusExpires
Simponi Solution for Injection in Prefilled Pen
Solution for injection
A6-100193active
Simponi 100 mg solution for injection PFP
Solution for injection
A6-0474active

GolimumabNAFDAC Registration Details

NAFDAC (Nigeria) has 2 registered products containing Golimumab, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.

Track Golimumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.